Visual pathway glioma: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 29: | Line 29: | ||
{{Eye-disease-stub}} | {{Eye-disease-stub}} | ||
{{Cancer-stub}} | {{Cancer-stub}} | ||
{{No image}} | |||
Revision as of 00:21, 11 February 2025
Visual pathway glioma (VPG) is a type of brain tumor that primarily affects children. It is a rare condition, accounting for approximately 5% of all central nervous system tumors in children.
Definition
Visual pathway gliomas are gliomas that occur in the optic nerve or other parts of the visual pathway. They are typically low-grade tumors, meaning they grow slowly and are less likely to spread to other parts of the body. However, they can cause significant visual impairment and other neurological symptoms.
Symptoms
The symptoms of visual pathway glioma can vary depending on the location of the tumor. Common symptoms include vision loss, strabismus (crossed eyes), nystagmus (involuntary eye movement), and proptosis (bulging eyes). Some patients may also experience headaches, nausea, and vomiting due to increased intracranial pressure.
Diagnosis
The diagnosis of visual pathway glioma is typically made based on magnetic resonance imaging (MRI) findings. An ophthalmologic examination may also be performed to assess visual function. In some cases, a biopsy may be needed to confirm the diagnosis.
Treatment
The treatment of visual pathway glioma depends on the size and location of the tumor, as well as the patient's symptoms and overall health. Treatment options may include observation, surgery, radiation therapy, and chemotherapy. In some cases, a combination of these treatments may be used.
Prognosis
The prognosis for patients with visual pathway glioma is generally good, especially for those with low-grade tumors. However, the condition can cause significant visual impairment and other neurological symptoms, which can impact the patient's quality of life.
See also
